Evidence map›Paper›PMID 38901116›Full record

ArticleThe journal of nutrition, health & aging2024

The association of non-severe COVID-19 infection and progression to frailty among robust older veterans.

Natasha M Resendes, Jerry Bradley, Fei Tang, Iriana S Hammel, Jorge G Ruiz

Abstract read
In one paragraph

Article in The journal of nutrition, health & aging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Change in frailty among older COVID-19 survivors.Journal of the American Geriatrics Society · 2024
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Natasha M ResendesMiami VA (Veterans Administration) Healthcare System Geriatric Research, Education and Clinical Center (GRECC), Miami, Florida, USA; Dept. of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA. Electronic address: natasha.resendes@va.gov.
Jerry BradleyDept. of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
Fei TangMiami VA (Veterans Administration) Healthcare System Geriatric Research, Education and Clinical Center (GRECC), Miami, Florida, USA.
Iriana S HammelMiami VA (Veterans Administration) Healthcare System Geriatric Research, Education and Clinical Center (GRECC), Miami, Florida, USA; Dept. of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
Jorge G RuizMemorial Healthcare System, Hollywood, Florida, USA; Dept of Medicine, Florida Atlantic University Charles E. Schmidt College of Medicine, Boca Raton, Florida, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies have shown that frailty was increased in hospitalized COVID-19 patients. However, it is not clear whether non-severe COVID-19 increases the risk for pre-frailty and frailty development. Our study aimed to determine the risk of developing frailty and pre-frailty in robust veterans who contracted non-severe COVID-19.

methodsWe conducted a retrospective cohort study to assess the association of SARS-CoV-2 infection with the development of pre-frailty and frailty status among robust U.S. veterans using VA COVID-19 Shared Data Resource. We included patients 55 years and older who had at least one SARS-CoV-2 testing between March 15, 2020, and November 30, 2020, had been active patients in the past 12 months, and had a VA frailty index of zero (robust status) at the time of testing. Cox proportional hazard model was used to assess the association between COVID-19 infection and developing frailty or pre-frailty and frailty. We also assessed the association by patients' age groups, sex, and race.

findingsWe identified 82070 veterans mean age 68.3 ± 7.8, 74738 (91.1%) male, 53899 (65.7%) white, 7557 (9.2%) with mild COVID-19 infection. Over the follow up period of 36 months, testing positive for COVID-19 was associated with a 66% increase in the hazard of becoming frail (adjusted HR = 1.66, 95%CI: 1.32-2.08), and a 68% increase in the hazard of becoming pre-frail (adjusted HR = 1.68, 95%CI: 1.45-1.94). Among male patients, mild COVID-19 infection was associated with a 54% increase in the hazard of becoming frail (adjusted HR = 1.54, 95% CI: 1.21-1.96), while among female patients there was a 330% increase (adjusted HR = 4.30, 95% CI: 2.13-8.64). CONCLUSIONS AND RELEVANCE: Non-severe COVID-19 infection that occurred in robust older adults increased the risk of developing frailty. Further multi-center prospective cohort studies evaluating the mechanism of action and clinical trials of treatment options for post-COVID frailty are indicated in Veterans to support clinical care.

Indexed as

FrailtyPost-Acute COVID-19 SyndromeSARS-CoV-2Severity of Illness IndexVeteransAgedAge FactorsDisease ProgressionFemaleHumansMaleMiddle AgedProportional Hazards ModelsRacial GroupsRetrospective StudiesRisk FactorsFrailtyNon-Severe COVID-19Veterans

Identifiers

PMID38901116
PMCPMC12878588

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.